PL3102613T3 - Cząsteczki polimerowe i ich zastosowania - Google Patents

Cząsteczki polimerowe i ich zastosowania

Info

Publication number
PL3102613T3
PL3102613T3 PL15746012T PL15746012T PL3102613T3 PL 3102613 T3 PL3102613 T3 PL 3102613T3 PL 15746012 T PL15746012 T PL 15746012T PL 15746012 T PL15746012 T PL 15746012T PL 3102613 T3 PL3102613 T3 PL 3102613T3
Authority
PL
Poland
Prior art keywords
polymer particles
particles
polymer
Prior art date
Application number
PL15746012T
Other languages
English (en)
Inventor
Bernd Helmut Adam Rehm
Original Assignee
Polybatics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53778236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3102613(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polybatics Limited filed Critical Polybatics Limited
Publication of PL3102613T3 publication Critical patent/PL3102613T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
PL15746012T 2014-02-04 2015-02-04 Cząsteczki polimerowe i ich zastosowania PL3102613T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ62068214 2014-02-04
PCT/NZ2015/050008 WO2015119512A1 (en) 2014-02-04 2015-02-04 Polymer particles and uses thereof
EP15746012.2A EP3102613B1 (en) 2014-02-04 2015-02-04 Polymer particles and uses thereof

Publications (1)

Publication Number Publication Date
PL3102613T3 true PL3102613T3 (pl) 2021-12-13

Family

ID=53778236

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15746012T PL3102613T3 (pl) 2014-02-04 2015-02-04 Cząsteczki polimerowe i ich zastosowania

Country Status (14)

Country Link
US (1) US10501505B2 (pl)
EP (1) EP3102613B1 (pl)
CY (1) CY1124491T1 (pl)
DK (1) DK3102613T3 (pl)
ES (1) ES2891973T3 (pl)
HK (1) HK1232241A1 (pl)
HR (1) HRP20211418T1 (pl)
HU (1) HUE056108T2 (pl)
LT (1) LT3102613T (pl)
PL (1) PL3102613T3 (pl)
RS (1) RS62375B1 (pl)
SI (1) SI3102613T1 (pl)
SM (1) SMT202100585T1 (pl)
WO (1) WO2015119512A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
CN109776661B (zh) * 2019-03-13 2022-08-09 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素ELISA检测用鸡尾酒刺激抗原
CN109776662B (zh) * 2019-03-13 2022-05-17 中国动物卫生与流行病学中心 一种用于牛结核病变态反应检测的鸡尾酒抗原
CN109813884A (zh) * 2019-03-25 2019-05-28 中国动物卫生与流行病学中心 一种牛结核病γ-干扰素快速检测制品
CN109813576B (zh) * 2019-03-25 2021-04-02 中国动物卫生与流行病学中心 一种牛结核病刺激上清制备用采血器
CN111269297B (zh) * 2020-01-23 2021-11-30 郑州伊美诺生物技术有限公司 一种结核分枝杆菌刺激抗原的制备方法
EP4132952A4 (en) * 2020-04-08 2024-10-02 Nanopin Technologies, Inc. MONOCLONAL ANTIBODIES AND THEIR USES
CN119823286B (zh) * 2025-01-16 2026-02-06 中国动物卫生与流行病学中心 一种重组蛋白抗原及其在制备用于检测牛伽马干扰素试剂盒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722840A (en) 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US20060024332A1 (en) 2004-08-02 2006-02-02 Waters Wade R Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
DK1929010T3 (en) * 2005-09-27 2014-03-10 Polybatics Ltd Use of the polymer particles
CN106421743A (zh) 2009-07-29 2017-02-22 贝恩德·赫尔穆特·阿达姆·雷姆 聚合物微粒及其用途
WO2012104791A1 (en) * 2011-02-01 2012-08-09 Bernd Helmut Adam Rehm Fusion polypeptides and uses thereof
WO2014009439A1 (en) * 2012-07-10 2014-01-16 Nec Europe Ltd. Reporting user related information in a mobile communication network

Also Published As

Publication number Publication date
EP3102613B1 (en) 2021-06-09
HUE056108T2 (hu) 2022-01-28
DK3102613T3 (da) 2021-09-13
SMT202100585T1 (it) 2021-11-12
LT3102613T (lt) 2021-09-27
SI3102613T1 (sl) 2021-11-30
US10501505B2 (en) 2019-12-10
CY1124491T1 (el) 2022-07-22
HK1232241A1 (zh) 2018-01-05
ES2891973T3 (es) 2022-02-01
RS62375B1 (sr) 2021-10-29
WO2015119512A1 (en) 2015-08-13
EP3102613A4 (en) 2017-12-20
US20170008938A1 (en) 2017-01-12
HRP20211418T1 (hr) 2021-12-24
EP3102613A1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
IL249186A0 (en) Anti-cd20 glycoantibodies and their uses
IL247014A0 (en) 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use
ZA201605858B (en) Novel polysaccharide and uses thereof
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
GB201405614D0 (en) Particles
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
EP3192815A4 (en) High-recoverability resin particles and use thereof
GB201512725D0 (en) Polymeric particles
EP3357934B8 (en) Polymer particles and use thereof
GB201503393D0 (en) Polymers and uses thereof
EP3229842A4 (en) Lipocationic polymers and uses thereof
SG11201607082PA (en) New tetracyano-anthraquino-dimethane polymers and use thereof
SG11201704473WA (en) New methods and uses
PL3102613T3 (pl) Cząsteczki polimerowe i ich zastosowania
EP3168250A4 (en) Fluorine-atom-containing polymer and use thereof
GB201412841D0 (en) Particles
IL248014B (en) Nanostructures and their applications
GB2543713B (en) Polymeric proteins and uses thereof
SG10201501373WA (en) Contrast Agent And Applications Thereof
GB201408091D0 (en) Methods and uses
IL251518B (en) Astaxanthin-based polymers and their uses
GB201407419D0 (en) Conductive materials and uses thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201416073D0 (en) Methods and uses
GB201416086D0 (en) Methods and uses